383 related articles for article (PubMed ID: 8914034)
1. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
[TBL] [Abstract][Full Text] [Related]
2. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
3. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.
Khosla S; Ebeling PR; Firek AF; Burritt MM; Kao PC; Heath H
J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032
[TBL] [Abstract][Full Text] [Related]
4. Influence of parathyroid mass on the regulation of PTH secretion.
Lewin E; Olgaard K
Kidney Int Suppl; 2006 Jul; (102):S16-21. PubMed ID: 16810305
[TBL] [Abstract][Full Text] [Related]
5. Calcium-sensing by parathyroid glands in secondary hyperparathyroidism.
Goodman WG; Veldhuis JD; Belin TR; Van Herle AJ; Juppner H; Salusky IB
J Clin Endocrinol Metab; 1998 Aug; 83(8):2765-72. PubMed ID: 9709944
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism.
Goodman WG; Veldhuis JD; Belin TR; Juppner H; Salusky IB
Kidney Int; 1997 May; 51(5):1590-5. PubMed ID: 9150477
[TBL] [Abstract][Full Text] [Related]
8. In vivo assessments of calcium-regulated parathyroid hormone release in secondary hyperparathyroidism.
Goodman WG; Belin TR; Salusky IB
Kidney Int; 1996 Dec; 50(6):1834-44. PubMed ID: 8943464
[TBL] [Abstract][Full Text] [Related]
9. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism.
Goodman WG; Belin T; Gales B; Juppner H; Segre GV; Salusky IB
Kidney Int; 1995 Nov; 48(5):1553-8. PubMed ID: 8544413
[TBL] [Abstract][Full Text] [Related]
10. Reversibility of experimental secondary hyperparathyroidism.
Lewin E; Wang W; Olgaard K
Kidney Int; 1997 Nov; 52(5):1232-41. PubMed ID: 9350646
[TBL] [Abstract][Full Text] [Related]
11. Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.
Nakajima K; Umino K; Azuma Y; Kosaka S; Takano K; Obara T; Sato K
J Bone Miner Metab; 2009; 27(2):224-33. PubMed ID: 19194773
[TBL] [Abstract][Full Text] [Related]
12. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy.
Schindler S; Mannstadt M; Urena P; Segre GV; Stein G
Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031
[TBL] [Abstract][Full Text] [Related]
13. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
Bas S; Aguilera-Tejero E; Bas A; Estepa JC; Lopez I; Madueño JA; Rodriguez M
J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid gland function in the uremic rabbit.
Bas S; Bas A; Estepa JC; Mayer-Valor R; Rodriguez M; Aguilera-Tejero E
Domest Anim Endocrinol; 2004 Mar; 26(2):99-110. PubMed ID: 14757183
[TBL] [Abstract][Full Text] [Related]
15. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
Lewin E; Garfia B; Recio FL; Rodriguez M; Olgaard K
J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
[TBL] [Abstract][Full Text] [Related]
16. Calcium-sensing receptor gene polymorphism affects the parathyroid response to moderate hypercalcemic suppression in patients with end-stage renal disease.
Yokoyama K; Shigematsu T; Tsukada T; Hara S; Yamada A; Kawaguchi Y; Hosoya T
Clin Nephrol; 2002 Feb; 57(2):131-5. PubMed ID: 11863123
[TBL] [Abstract][Full Text] [Related]
17. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
Salusky IB; Goodman WG
Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632
[TBL] [Abstract][Full Text] [Related]
18. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
[TBL] [Abstract][Full Text] [Related]
19. Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism.
Wallfelt C; Gylfe E; Larsson R; Ljunghall S; Rastad J; Akerström G
J Endocrinol; 1988 Mar; 116(3):457-64. PubMed ID: 3351432
[TBL] [Abstract][Full Text] [Related]
20. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
Firek AF; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
